Cargando…

Separase is a marker for prognosis and mitotic activity in breast cancer

BACKGROUND: Cancer cell proliferation is a critical feature in classifying and predicting the outcome of breast carcinoma. Separase has a central role in cell cycle progression in unleashing sister-chromatids at anaphase onset. Abnormally functioning separase is known to lead to chromosomal instabil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gurvits, Natalia, Löyttyniemi, Eliisa, Nykänen, Marjukka, Kuopio, Teijo, Kronqvist, Pauliina, Talvinen, Kati
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672940/ https://www.ncbi.nlm.nih.gov/pubmed/28859055 http://dx.doi.org/10.1038/bjc.2017.301

Ejemplares similares

PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival
por: Repo, Heli, et al.
Publicado: (2017)

A prognostic model based on cell-cycle control predicts outcome of breast cancer patients
por: Repo, Heli, et al.
Publicado: (2020)

Securin promotes the identification of favourable outcome in invasive breast cancer
por: Talvinen, K, et al.
Publicado: (2009)

Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer
por: Talvinen, K, et al.
Publicado: (2008)

Cdc20 and securin overexpression predict short-term breast cancer survival
por: Karra, H, et al.
Publicado: (2014)

Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer
por: Ishikawa, K, et al.
Publicado: (2008)

The Reproducibility of Nuclear Morphometric Measurements in Invasive Breast Carcinoma
por: Kronqvist, Pauliina, et al.
Publicado: (1997)

Predicting aggressive outcome in T1N0M0 breast cancer
por: Kronqvist, P, et al.
Publicado: (2004)

Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors
por: Uusitalo, Elina, et al.
Publicado: (2017)

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
por: Khan, M S, et al.
Publicado: (2013)

Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivo
por: Winsel, S, et al.
Publicado: (2014)

Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer
por: Ueo, H, et al.
Publicado: (2015)

Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
por: Frödin, Magnus, et al.
Publicado: (2017)

Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients
por: Ruiz, M I Galleges, et al.
Publicado: (2009)

UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer
por: Unoki, M, et al.
Publicado: (2009)

miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions
por: Grignol, V, et al.
Publicado: (2011)

Arpin downregulation in breast cancer is associated with poor prognosis
por: Lomakina, Maria E, et al.
Publicado: (2016)

Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer
por: Nakamura, Y, et al.
Publicado: (2007)

Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer
por: Kronqvist, P, et al.
Publicado: (2002)

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma
por: Yuen, H-F, et al.
Publicado: (2007)

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer
por: Zlobec, I, et al.
Publicado: (2008)

Hypoxia-associated markers in gastric carcinogenesis and HIF-2α in gastric and gastro-oesophageal cancer prognosis
por: Griffiths, E A, et al.
Publicado: (2008)

Nuclear osteopontin-c is a prognostic breast cancer marker
por: Zduniak, K, et al.
Publicado: (2015)

Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2017)

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma
por: Saroufim, A, et al.
Publicado: (2014)

Epstein-Barr virus as a marker of biological aggressiveness in breast cancer
por: Mazouni, C, et al.
Publicado: (2011)

Lack of correlation of stem cell markers in breast cancer stem cells
por: Liu, Y, et al.
Publicado: (2014)

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers
por: Sung, Hyuna, et al.
Publicado: (2016)

GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma
por: Xue, Y, et al.
Publicado: (2014)

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas
por: Deb, S, et al.
Publicado: (2014)

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
por: Krenn-Pilko, S, et al.
Publicado: (2014)

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples
por: Kazarian, Anna, et al.
Publicado: (2017)

The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer
por: Beresford, M J, et al.
Publicado: (2006)

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis
por: Zheng, H-C, et al.
Publicado: (2006)

Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma
por: Tanaka, N, et al.
Publicado: (2008)

A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer
por: Tsutsui, S, et al.
Publicado: (2006)

Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer
por: Ali, A M G, et al.
Publicado: (2011)

miR-30e* is an independent subtype-specific prognostic marker in breast cancer
por: D'Aiuto, F, et al.
Publicado: (2015)

Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
por: Sjöberg, Elin, et al.
Publicado: (2016)

Urinary N(1), N(12)-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer
por: Takahashi, Yusuke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9m69jquejq9hiv4dk3n7d05ukl